Australia - English - Department of Health (Therapeutic Goods Administration)

ge healthcare australia pty ltd - cyanocobalamin (57co), quantity: 18.5 kbq - capsule, hard - excipient ingredients: benzyl alcohol; lactose monohydrate; gelatin; quinoline yellow; erythrosine - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) indications as at 23 may 2005 : cyanocobalamin [57co] capsules are indicated for vitamin b12 malabsorption tests.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - cyanocobalamin, quantity: 1 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium chloride - 1. pernicious anaemia as a result of in situ b12 deficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - cyanocobalamin, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid - cobalamin deficiency may exist that is unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of vitamin b12 may be insufficient in pernicious anaemia, malabsorption disorders, gastrectomy and gastrointestinal pathologies. specific indications may include: 1. pernicious anaemia as a result of in situ b12 deficiency.

Australia - English - Department of Health (Therapeutic Goods Administration)

cyanocobalamin -

United States - English - NLM (National Library of Medicine)

oaklock, llc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 1000 ug in 1 ml

United States - English - NLM (National Library of Medicine)

it3 medical llc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions: addisonian (pernicious) anemia gastrointestinal pathology, dysfunction, or surgery, including gluten enteropathy or sprue, small bowel bacteria overgrowth, total or partial gastrectomy fish tapeworm infestation malignancy of pancreas or bowel folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth, expulsion of fish tapeworm, discontinuation of drugs leading to vitamin malabsorption (see drug interactions ), use of a gluten-free diet in nontropical sprue, or administration of antibiotics in tropical sprue. such measures remove the need for long-term administration of cyanocobalamin. requirements of vitamin b12 in excess of normal (due to pregnancy, thyrotoxicosis, hemolytic anemia, hemorrhage, malignancy, hepatic and renal disease) can usually be met with oral supplementatio

United States - English - NLM (National Library of Medicine)

zydus lifesciences limited - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) -

United States - English - NLM (National Library of Medicine)

par pharmaceutical , inc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - cyanocobalamin 500 ug - nascobal nasal spray is indicated for the maintenance of normal hematologic status in pernicious anemia patients who are in remission following intramuscular vitamin b12 therapy and who have no nervous system involvement. nascobal nasal spray is also indicated as a supplement for other vitamin b12 deficiencies, including:    i. dietary deficiency of vitamin b12 occurring in strict vegetarians (isolated vitamin b12 deficiency is very rare).    ii. malabsorption of vitamin b12 resulting from structural or functional damage to the stomach, where intrinsic factor is secreted, or to the ileum, where intrinsic factor facilitates vitamin b12 absorption. these conditions include hiv infection, aids, crohn's disease, tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy). folate deficiency in these patients is usually more severe than vitamin b12 deficiency.    iii. inadequate secretion of intrinsic factor, resulting from lesions that destroy the gastric mucosa (ingesti

United States - English - NLM (National Library of Medicine)

sparhawk laboratories, inc. - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (riboflavin - unii:tlm2976ofr), thiamine hydrochloride (unii: m572600e5p) (thiamine - unii:x66nso3n35) - cyanocobalamin 100 ug in 1 ml - for use as a supplement source of b complex vitamins in cattle, swine and sheep.

United States - English - NLM (National Library of Medicine)

gensavis pharmaceuticals, llc - cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), vitamin d (unii: 9vu1ki44gp) (vitamin d - unii:9vu1ki44gp), .alpha.-tocopherol (unii: h4n855pnz1) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:267 - cyanocobalamin 2 ug in 1 ml - shake well before use . as a dietary supplement for infants and children under 4 years of age: 1 ml dropper daily unless otherwise directed by physician.